Accelerating Clean Energy Technology Research, Development, and Deployment: Lessons from Non-energy Sectors by Patrick Avato & Jonathan Coony

Author:Patrick Avato & Jonathan Coony
Language: eng
Format: epub
ISBN: 9780821374818
Publisher: The World Bank
Published: 2009-06-28T16:00:00+00:00

Pilot AMC

The GAVI Alliance and the World Bank designed a public AMC for pneumococcal vaccines to demonstrate its impact on accelerating vaccine development, production scale-up, and introduction. Pneumonia is the leading infectious cause of childhood mortality worldwide. An estimated 1.9 million (or 19 percent) of the estimated 10 million child deaths each year result from pneumonia. Pneumococcal disease is the leading cause of these child pneumonia deaths, as well as the second-leading cause of childhood meningitis deaths. Pneumococcal disease kills more than 1.6 million people each year, including 700,000 to 1 million children under 5 years of age. An independent expert committee, with representation from developing and industrialized countries assessed six potentially vaccine-preventable diseases and recommended that pneumococcal disease be the target of the initial market commitment.

In February 2007 a consortium of donors pledged to support the pilot with $1.5 billion in commitments (see table 3).

Table 3. AMC Donors Commitments for a Pneumococcal Vaccine Donor AMC Contribution

Italy

$635 million

United Kingdom $485 million

Canada $200 million

Russian Federation $80 million

Norway $50 million

Bill & Melinda Gates Foundation $50 million

Total $1.5 billion

Sources: www.vaccineamc.org

Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.